In vitro safety evaluation of dopamine D3R antagonist, R-VK4-116, as a potential medication for the treatment of opioid use disorder

In vitro safety evaluation of dopamine D3R antagonist, R-VK4-116, as a potential medication for the treatment of opioid use disorder

Saved in:

Bibliographic Details
Main Authors:	Rahul M. Nandre, Amy Hauck Newman, Pramod S. Terse
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11649115/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Generalized cue reactivity in rat dopamine neurons after opioids
by: Collin M. Lehmann, et al.
Published: (2025-01-01)

Left ventromedial prefrontal cortex inhibitory rTMS as an anti-stress intervention in opioid use disorder: Trial design
by: Tabitha E. Moses, et al.
Published: (2025-02-01)

Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response
by: Jing Sun, et al.
Published: (2023-11-01)

Development of Trp-AuNPs-rGO based electrochemical active biosensing interface for dopamine detection
by: Jyoti Varma, et al.
Published: (2024-12-01)

Correction: Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response
by: Jing Sun, et al.
Published: (2024-11-01)

Dopamine Dysregulation Syndrome Mimicking Ultradian Cycling Bipolar Disorder in Parkinson’s Disease
by: Samarth Shetty, et al.
Published: (2024-11-01)

Changing content plan structure of companies operating in Russia and represented on VK
by: L. G. Akhmaeva, et al.
Published: (2023-10-01)

The Inhibitory Effect and Mechanism of the Histidine-Rich Peptide rAj-HRP from <i>Apostichopus japonicus</i> on Human Colon Cancer HCT116 Cells
by: Yuebin Zhang, et al.
Published: (2024-11-01)

The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells.
by: Daniela Russo, et al.
Published: (2024-01-01)

Dopamine Appetite and Cognitive Impairment in Attention Deficit/Hyperactivity Disorder
by: Jonathan Williams, et al.
Published: (2004-01-01)

V.K. Malmberg, the classic of the Russian study of antiquity: The Kazan period in his biography
by: L.A. Sychenkova
Published: (2022-12-01)

Ethnonational discourse of migrants in social networks on the example of Tajik and Kyrgyz virtual communities on VK
by: T. N. Yudina, et al.
Published: (2023-10-01)

In silico evaluation, characterization, and in vitro anticancer activity of curcumin–nimbin loaded nanoformulation in HCT-116 cell lines
by: Arumugam Madeswaran, et al.
Published: (2024-12-01)

Effect of N-Methyl-D-Aspartate Receptor Antagonist Dextromethorphan on Opioid Analgesia in Pediatric Intensive Care Unit
by: Mohammed Naeem, et al.
Published: (2016-01-01)

(R)evolution of performance in the public order and safety system
by: Elena Casandra Ceausescu, et al.
Published: (2024-11-01)

Therapeutic Application of rTMS in Atypical Parkinsonian Disorders
by: Chrysi Petsani, et al.
Published: (2021-01-01)

Lactobacillus spp. inhibits the growth of HCT-116 and reduces IL-8 secretion by Salmonella typhimurium-infected HCT-116 colorectal carcinoma cells
by: Cheng-Chih Tsai, et al.
Published: (2022-10-01)

CANDU Safety R&D Status, Challenges, and Prospects in Canada
by: W. Shen, et al.
Published: (2015-01-01)

Effects of Chronic Dopamine D2R Agonist Treatment and Polysialic Acid Depletion on Dendritic Spine Density and Excitatory Neurotransmission in the mPFC of Adult Rats
by: Esther Castillo-Gómez, et al.
Published: (2016-01-01)

Montauban (Tarn-et-Garonne). 116, boulevard de Montauriol
by: Patrice Georges
Published: (2012-12-01)

Proportionality in Australian Constitutional Law: Next Stop Section 116?
by: Anthony Gray
Published: (2022-01-01)

Generalized R′-Implications: A Hyper Class of R- and R′-Implications
by: Dimitrios S. Grammatikopoulos, et al.
Published: (2023-01-01)

Influence of Angiotensin II Subtype 2 Receptor (AT2R) Antagonist, PD123319, on Cardiovascular Remodelling of Aged Spontaneously Hypertensive Rats during Chronic Angiotensin II Subtype 1 Receptor (AT1R) Blockade
by: Emma S. Jones, et al.
Published: (2012-01-01)

Effect of Antagonists and Botanicals Against Xanthomonas oryzae pv. oryzae In Vitro
by: Bhukya Srinivas, et al.
Published: (2024-02-01)

Teletherapy could miss a distinct group among patients with pain and opioid use disorder
by: Sarah C. Wilson, et al.
Published: (2024-11-01)

Evaluating comparative effectiveness of psychosocial interventions for persons receiving opioid agonist therapy for opioid use disorder: protocol for a systematic review
by: Brian Hutton, et al.
Published: (2018-10-01)

Influence of opioid peptides on human neutrophil apoptosis and activation in vitro
by: Zofia Sulowska, et al.
Published: (2002-01-01)

Evaluating the antagonist effect of naltrexone implant via opioid challenge tests with escalating doses of hydromorphone injection in former heroin dependent patients
by: Wei Qu, et al.
Published: (2025-01-01)

Montauban (Tarn-et-Garonne). 116 boulevard Montauriol – IFSI-IFAS
by: Julien Foltran
Published: (2020-12-01)

The Role of Indoxyl Sulfate in Exacerbating Colorectal Cancer During Chronic Kidney Disease Progression: Insights into the Akt/β-Catenin/c-Myc and AhR/c-Myc Pathways in HCT-116 Colorectal Cancer Cells
by: Yu Ichisaka, et al.
Published: (2025-01-01)

Serotonin circuits act cooperatively with pathophysiology of opioid use disorder
by: Arakawa Hiroyuki, et al.
Published: (2025-03-01)

Disparities in Opioid Use Disorder Treatment Admissions in the United States
by: Peter J. Mallow, et al.
Published: (2020-06-01)

Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder
by: Nicholas C. Cardamone, et al.
Published: (2025-02-01)

Association between different modalities of opioid use disorder-related care delivery and opioid use disorder-related patient outcomes: A retrospective cohort study
by: Nahiyan Bin Noor, et al.
Published: (2025-06-01)

Dopamine Agonists and Pathologic Behaviors
by: Brendan J. Kelley, et al.
Published: (2012-01-01)

Immunomodulatory Effects Mediated by Dopamine
by: Rodrigo Arreola, et al.
Published: (2016-01-01)

Fuzzy r-continuous and fuzzy r-semicontinuous maps
by: Seok Jong Lee, et al.
Published: (2001-01-01)

Differentiation value of miR-26b for major depressive disorder, schizophrenia, generalized anxiety disorder
by: Lingming Kong, et al.
Published: (2023-07-01)

miR-193b-5p and miR-374b-5p Are Aberrantly Expressed in Endometriosis and Suppress Endometrial Cell Migration In Vitro
by: Caroline Frisendahl, et al.
Published: (2024-11-01)

Identification of new process-related impurity in the key intermediate in the synthesis of TCV-116
by: Testen Ana, et al.
Published: (2019-03-01)